IBT B — Infant Bacterial Therapeutics AB Balance Sheet
0.000.00%
- SEK1.31bn
- SEK997.11m
Annual balance sheet for Infant Bacterial Therapeutics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 495 | 423 | 387 | 336 | 329 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.713 | 1.96 | 1.2 | 1.78 | 6.74 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 505 | 438 | 397 | 339 | 342 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 518 | 450 | 408 | 350 | 351 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7.88 | 10.2 | 13.2 | 17.9 | 46.2 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 7.88 | 10.2 | 13.2 | 17.9 | 46.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 510 | 440 | 395 | 332 | 305 |
Total Liabilities & Shareholders' Equity | 518 | 450 | 408 | 350 | 351 |
Total Common Shares Outstanding |